GLP-1s are peptides. Semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), and liraglutide (Saxenda) are all peptide drugs — short chains of amino acids engineered to mimic the gut hormone GLP-1. So "peptides vs GLP-1s" isn't really a matchup between two different things. It's a comparison between one specific family of peptides and everything else people mean by "peptides."
The short answer: GLP-1 peptides are the most powerful weight-loss medications available, producing 15–22% average body-weight loss by reducing appetite. Other peptides — such as CJC-1295 + ipamorelin, tesamorelin, BPC-157, and MOTS-c — work through different pathways and target goals like visceral fat, lean muscle, recovery, sleep, and metabolic health. Many people use them alongside a GLP-1, not instead of one.
Yes. GLP-1 (glucagon-like peptide-1) is itself a peptide hormone made in your gut after you eat. Natural GLP-1 breaks down within about two minutes, so drug makers modified its amino-acid sequence to make it last much longer:
Not every GLP-1 drug is a peptide, though. Orforglipron is a small-molecule pill that activates the GLP-1 receptor without being a peptide at all.
"Peptides" is a broad category: any chain of roughly 2 to 50 amino acids. Insulin, oxytocin, and growth hormone–releasing hormone are all peptides. When people talk about "peptide therapy," they usually mean a group of non-GLP-1 peptides used for:
For an overview of all of them, see what are the best peptides.
GLP-1s work mainly by making you eat less. They act on the brain's appetite centers to increase fullness and reduce cravings, slow stomach emptying, and boost insulin release when blood sugar rises. Their effects reach the brain, gut, pancreas, liver, and heart.
Growth hormone peptides work by changing how your body uses energy. Higher growth hormone shifts metabolism toward burning fat — especially visceral (belly) fat — and supports protein synthesis in muscle. They don't meaningfully suppress appetite. Some, like ipamorelin, can actually increase hunger.
Recovery and metabolic peptides work at the tissue level. BPC-157 is studied for tendon and gut repair, MOTS-c for insulin sensitivity and mitochondrial function, and GHK-Cu for collagen production.
GLP-1s win by a wide margin for total weight loss.
No growth hormone or recovery peptide comes close to those numbers. Their role is different.
Here's where other peptides earn their place. Tesamorelin specifically targets visceral fat — the deep abdominal fat linked to heart disease and diabetes — and reduced it by about 15% in 26 weeks without significant changes in overall body weight. That makes it useful for people who aren't heavy but carry fat around the middle.
GLP-1s reduce visceral fat too, as part of overall weight loss. But when weight drops quickly, a meaningful share of it can be lean mass. With tirzepatide, roughly three-quarters of weight lost is fat and about one-quarter is lean tissue. Growth hormone peptides, resistance training, and protein are the main tools for protecting muscle during that process.
Compare options in peptides for weight loss and best peptides for fat loss.
GLP-1s have the strongest evidence here. In the SELECT trial, semaglutide cut major cardiovascular events by 20% in people with heart disease and overweight but no diabetes. GLP-1s also lower A1C, blood pressure, and liver fat.
Other peptides have smaller, earlier-stage metabolic data. Tesamorelin improves liver fat and triglycerides in some studies; MOTS-c has promising animal data on insulin sensitivity.
Mostly digestive, and most common as the dose increases:
Less common but important: gallbladder problems, pancreatitis, and dehydration from vomiting.
Growth hormone peptides are generally mild:
Yes, and it's a common approach. Because they work through different pathways, many clinicians pair a GLP-1 with other peptides to cover gaps:
What you shouldn't do is combine two GLP-1 drugs (for example semaglutide and tirzepatide) — they act on the same receptor and side effects stack. Any combination should be reviewed by a clinician who knows your full medication list.
Choose a GLP-1 if you:
Choose other peptides if you:
Use both if you're losing weight on a GLP-1 and want to protect muscle or target visceral fat along the way.
Yes. Semaglutide is a modified version of the GLP-1 peptide hormone, engineered to last about a week in the body.
Yes. Tirzepatide is a 39-amino-acid peptide that activates both GIP and GLP-1 receptors.
No. Growth hormone, recovery, and metabolic peptides don't produce the 15–20%+ weight loss seen with GLP-1 drugs. They're better suited to body composition, visceral fat, and recovery.
Other incretin peptides — tirzepatide (GIP + GLP-1) and retatrutide (GIP + GLP-1 + glucagon). See retatrutide vs tirzepatide.
Growth hormone peptides like CJC-1295 + ipamorelin may help, alongside resistance training and enough protein. Read our guide to the best peptides for muscle growth.
Most don't. GLP-1 peptides are uniquely appetite-suppressing. Ghrelin-mimicking peptides like ipamorelin can actually increase hunger.
They work through different pathways and are sometimes combined under clinician supervision — tirzepatide for overall weight loss, tesamorelin for visceral fat.
They contain the same active peptide but are made by compounding pharmacies rather than the brand manufacturer. Quality depends on the pharmacy — see research-grade peptides vs licensed pharmacies.
GLP-1s are peptides — the most powerful weight-loss peptides available. They work by curbing appetite and deliver 15–22% average weight loss. Other peptides work through growth hormone, tissue repair, and mitochondrial pathways, making them better for visceral fat, lean muscle, recovery, and energy. The two aren't rivals; for many people, they work best together.
Bowery Clinic offers tirzepatide, tesamorelin, CJC-1295 + ipamorelin, and our Form body-composition blend after a quick online evaluation. See what our patients say.
